← The Wire
EWNYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · CIK 1099800
Edwards Lifesciences develops innovative structural heart and critical care technologies to improve patient lives
red 8-K · 90d🔥 High media attention
$49.01B
Market cap
$91.18
Last close
+0.4%
1D
+6.2%
5D
3.6M
Volume
Price · last 39 sessions+9.4%
May 4L $77.17 · H $91.18Jun 29
130
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AMar 26, 2026DEFA14ADEFA14AMar 26, 2026DEFA14ADEFA14AApr 14, 2025DEFA14ADEFA14AMar 26, 2025DEFA14ADEFA14AMar 26, 2025DEFA14ADEFA14AMar 26, 2024DEFA14ADEFA14AMar 26, 2024DEFA14ADEFA14AMar 28, 2023DEFA14ADEFA14AMar 28, 2023DEFA14ADEFA14AMar 22, 2022DEFA14ADEFA14AMar 22, 2022DEFA14ADEFA14AMar 23, 2021DEFA14ADEFA14AMar 23, 2021DEFA14ADEFA14AApr 13, 2020DEFA14ADEFA14AMar 25, 2020DEFA14ADEFA14AMar 25, 2020DEFA14ADEFA14AMar 27, 2019DEFA14ADEFA14AMar 27, 2019
Insider Activity
In the 90 days to Mar 11, 2026: 6 sold $8.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 7,901 | $85.21 | $673K |
| Mar 11, 2026 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 5,099 | $84.46 | $431K |
| Mar 11, 2026 | Lippis Daniel J.CVP, TAVR | Sell | 1,019 | $85.38 | $87K |
| Mar 2, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974K |
| Feb 25, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.0M |
| Feb 12, 2026 | Zovighian Bernard JCEO | Sell | 19,898 | $76.61 | $1.5M |
| Feb 12, 2026 | Zovighian Bernard JCEO | Sell | 2,532 | $77.13 | $195K |
| Jan 9, 2026 | Lippis Daniel J.CVP, TAVR | Sell | 1,019 | $85.70 | $87K |
| Jan 6, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 8,708 | $85.98 | $749K |
| Jan 6, 2026 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 2,632 | $84.62 | $223K |
| Dec 12, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 5,900 | $83.74 | $494K |
| Dec 12, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 5,486 | $83.79 | $460K |
| Dec 12, 2025 | Stone Heisz LeslieDirector | Sell | 2,615 | $83.41 | $218K |
| Dec 12, 2025 | Lippis Daniel J.CVP, JAPAC | Sell | 1,019 | $84.03 | $86K |
| Dec 11, 2025 | Chopra DaveenCVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $169K |
| Dec 10, 2025 | Bobo Donald E JrCVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $951K |
| Dec 10, 2025 | Zovighian Bernard JCEO | Sell | 3,863 | $83.45 | $322K |
| Dec 9, 2025 | Ullem Scott B.CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650K |
| Dec 8, 2025 | Zovighian Bernard JCEO | Sell | 21,487 | $85.21 | $1.8M |
| Dec 8, 2025 | Markowitz WayneCVP, JAPAC | Sell | 583 | $86.01 | $50K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 10 reputable articles.
MarketWatchEdwards Lifesciences Corp. stock outperforms competitors on strong trading day3d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains6d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Monday when compared to competitors7d agoMarketWatchEdwards Lifesciences Corp. stock outperforms competitors despite losses on the day12d agoMarketWatchEdwards Lifesciences Corp. stock rises Monday, still underperforms market14d agoMarketWatchEdwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains25d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance